Preparation of Sesquiterpene Lactone Derivatives: Cytotoxic Activity and Selectivity of Action

Area of Science:

• Natural Product Chemistry
• Medicinal Chemistry
• Pharmacology

Background:

• Cancer remains a leading global cause of death, with solid tumors comprising over 90% of cases.
• Current chemotherapy for solid tumors exhibits variable efficacy and significant toxicity.
• Sesquiterpene lactones are natural compounds known for their diverse biological activities, including cytotoxicity.

Purpose of the Study:

• To synthesize and evaluate novel oxygenated and oxy-nitrogenated derivatives of sesquiterpene lactones.
• To identify compounds with enhanced antitumor activity and selectivity against various cancer cell lines.
• To assess the toxicity profile of promising derivatives on normal cells.

Main Methods:

• Synthesis of a series of derivatives (4-15) from cumanin, helenalin, and hymenin.
• In vitro evaluation of cytotoxic activity against human tumor cell lines using GI50 values.
• Assessment of selectivity by comparing tumor cell cytotoxicity (GI50) with normal splenocyte toxicity (CC50).

Main Results:

• Silylated helenalin derivatives (13, 14) exhibited high activity with GI50 values from 0.15 to 0.59 μM.
• The ditriazolyl cumanin derivative (11) showed superior activity and selectivity compared to parent cumanin across breast, cervix, lung, and colon cancer cell lines.
• Compound 11 displayed low toxicity to splenocytes (CC50 = 524.1 µM) and a high selectivity index (SI = 227.9) against WiDr colon cancer cells.

Conclusions:

• Compound 11, a novel ditriazolyl cumanin derivative, is a highly promising candidate for further development as an anticancer agent.
• The synthesized derivatives, particularly compound 11, offer a potential new avenue for more effective and selective cancer chemotherapy.
• Further preclinical studies are warranted to explore the therapeutic potential of compound 11 in solid tumor treatment.